Sign Up Today and Learn More About Ambrosia Biosciences Stock
Invest in or calculate the value of your shares in Ambrosia Biosciences or other pre-IPO companies through EquityZen's platform.
Ambrosia Biosciences Stock
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
About Ambrosia Biosciences Stock
Founded
2024
Headquarters
Boulder, CO, US
Industries
Science and Engineering, Health Care, Biotechnology
Ambrosia Biosciences Press Mentions
Stay in the know about the latest news on Ambrosia Biosciences
The biggest biotech funding rounds in March 2026
labiotech • Apr 08, 2026
Ambrosia Biosciences Announces $100 Million Series B
vcnewsdaily • Apr 07, 2026
앰브로시아 1억 달러 투자유치.. “펩타이드 한계 넘는 차세대 경구 비만 치료제 개발”
wowtale • Apr 05, 2026
The Week’s 10 Biggest Funding Rounds: Largest Financings Went To Defense, Wearables, Energy And Security
news • Apr 05, 2026
Ambrosia slurps up a $100M series B for its oral obesity drug pipeline
bioworld • Apr 04, 2026
Ambrosia Biosciences Management
Leadership team at Ambrosia Biosciences
Board Member
Sara Clarke
Join now and verify your accreditation status to gain access to:
- Ambrosia Biosciences Current Valuation
- Ambrosia Biosciences Stock Price
- Ambrosia Biosciences Management
- Available deals in Ambrosia Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ambrosia Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Ambrosia Biosciences Revenue and Financials
- Ambrosia Biosciences Highlights
- Ambrosia Biosciences Business Model
- Ambrosia Biosciences Risk Factors
- Ambrosia Biosciences Research Report from SACRA Research
Trading Ambrosia Biosciences Stock
How to invest in Ambrosia Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Ambrosia Biosciences through EquityZen funds. These investments are made available by existing Ambrosia Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Ambrosia Biosciences stock?
Shareholders can sell their Ambrosia Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."